3rd Quarter - Report
SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to patient access to treatments Issues related to rare diseases, including Duchenne Muscular Dystrophy Issues related to newborn screening for rare diseases Issues related to scientific innovation in healthcare, including gene therapies Public Law 117-169, Inflation Reduction Act of 2022; Provisions related to prescription drugs
| Lobbyist | Covered position, as disclosed |
|---|---|
| CAROLYN HICKEY | — |
| KIP PAYNE | — |
Taxation/Internal Revenue Code TAX
Tax issues related to research and development
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIP PAYNE New | — |
Science/Technology SCI
Issues related to artificial intelligence and data governance
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIP PAYNE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.